出品:医药魔方媒体
文案:白露
绘制及排版:辛格、珂珂
监制:曼话、MS
[1]Robbie G. Majzner, et al. Clinical lessons learned from the first leg of the CAR T cell journey. Nature Medicine. (2019) [2]Roddie, C., et al. Manufacturing chimeric antigen receptor T cells: issues and challenges. Cytotherapy. (2019)[3]Rebecca C. Larson, et al. Recent advances and discoveries in the mechanisms and functions of CAR T cells. (2021)[4]Robert C. Sterner, et al. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer Journal. (2021) [5]Andrew J. Hou, et al. Navigating CAR-T cells through the solid-tumour microenvironment. Nature Reviews Drug Discovery. (2021) [6]S. Depil, et al. ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges. Nature Reviews Drug Discovery . (2020) 来源:医药魔方